CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Colorectal Cancer

 

PET Scans Link Low Dopamine Levels and Aggression

By Marijke Vroomen Durning, RN | June 12, 2012

PET imaging has demonstrated a link between low dopamine(Drug information on dopamine) levels and aggression in young healthy adults — surprisingly opposite results from what was previously hypothesized, said researchers in a presentation at the Society of Nuclear Medicine’s Annual Meeting, in Miami Beach, Fla., this week.

The neurobiology of aggression is not well understood, but researchers have been aware that there is a relationship between serotonin, a neurotransmitter, and certain aggressive behaviors. To investigate this further, researchers from RWTH Aachen University in Aachen, Germany, assessed 18 healthy adults in their 20s for aggression using the psychological behavioral task known as point subtraction aggression paradigm (PSAP). They wanted to determine if higher levels of dopamine, involved in pleasure and reward, increased aggressiveness, but the results weren’t as theorized.

(MORE: The Push for Coverage of PET Tracers)

By playing a computer game, in which the participants were told that an opponent in another room would be able to cheat and steal some of the participants’ winnings, the subjects could punish the cheater (who did not exist in reality), shield against the adversary by repeatedly pressing a defense button, or continue to play the game in order to maximize their ability to win cash. This indicated resilience.

The subjects underwent PET scanning with F-18 FDOPA, a biomarker that lights up enzymes’ ability to synthesize serotonin. The uptake was analyzed to gauge the correlation between the subjects’ dopamine synthesis capacity and aggressive behavior.

The researchers found that there was a significant impact on aggressive response in areas in the brain where dopamine synthesis was present, especially in the basal ganglia, which among other functions, include the motivation center. Minimized aggression was associated with higher dopamine levels in both the midbrain and the striatum, which plays a role in planning and investigative functioning.

Focus on the monetary reward aspect of the PSAP was seen among subjects with a greater capacity for dopamine synthesis, while those with lower capacities had higher vulnerability to act either aggressively, defensively, or both, researchers said.

“We think that a well-functioning reward system causes more resilience against provocation,” said lead author Ingo Vernaleken, MD. “However, we cannot exclude that in a situation where the subject would directly profit from aggressive behavior, in absence of alternatives, the correlation may be the other way around.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Related Content

PET/CT Aids Neuroendocrine Cancer Treatment Planning

PET Scans Link Low Dopamine Levels and Aggression

PET Predicts Outcomes for Glioma, Colorectal Cancer Tx

PET/MR: How Feasible is Implementation?

PET/CT Predicts Survival in Breast Cancer Patients with Hepatic Metastases

PET with FDG May Predict Outcomes in Triple-Negative Breast Cancer

PET Tracer Shows Active Brains Have Less Beta-Amyloid

Imaging Detects Alzheimer’s Before Onset of Cognitive Decline

The Push for Coverage of PET Tracers






 
RELATED CONTENT

Axitinib Fails to Improve Survival in Metastatic Colorectal Cancer
May 6, 2013
A 47-Year-Old Patient With Chronic Abdominal Pain
April 26, 2013
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22, 2013
Smoking Linked to Poorer Prognosis in Colon Cancer
April 13, 2013
Colorectal Lesions
March 8, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SEARCH MEDICA SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Colorectal Cancer
Evidence on Colorectal Cancer
Guidelines on Colorectal Cancer
Patient Education on Colorectal Cancer
Clinical Trials on Colorectal Cancer
Practical Articles on Colorectal Cancer
Research and Reviews on Colorectal Cancer
All "Colorectal Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy